HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice.

Abstract
Although it is known that two-tier serologic testing for Lyme disease may be associated with false positive results on the IgM immunoblot, this problem has never been systematically studied in the clinical practice setting. In a retrospective investigation of patients referred to the private adult practice of an Infectious Diseases physician for possible for Lyme disease, 50 of 182 patients (27.5%, 95% CI: 21.1-34.6) were found to have a false positive IgM immunoblot. 78.0% of these patients had received unnecessary antibiotic therapy. False positive results were not restricted to any single commercial laboratory. Research on alternative testing strategies that eliminate the IgM immunoblot entirely is warranted.
AuthorsV Seriburi, N Ndukwe, Z Chang, M E Cox, G P Wormser
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 18 Issue 12 Pg. 1236-40 (Dec 2012) ISSN: 1469-0691 [Electronic] England
PMID22369185 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin M
Topics
  • Adult
  • Aged
  • Antibodies, Bacterial (blood)
  • Borrelia burgdorferi (immunology)
  • Clinical Laboratory Techniques (methods)
  • False Positive Reactions
  • Female
  • Humans
  • Immunoblotting (methods)
  • Immunoglobulin M (blood)
  • Lyme Disease (diagnosis)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: